Too much piling up on the bear side for AKRX; SEC late filings, FDA violations, bear technicals, looming Hillary and drug price pressure
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
